Skip to main content

UM SOM Researcher Dr. Kathleen Neuzil Honored by Vanderbilt University School of Medicine

April 12, 2016

Kathleen Neuzil, MD, MPH

The Vanderbilt University School of Medicine (VUSM) has announced that Kathleen Neuzil, MD, MPH, director of the Center for Vaccine Development at the University of Maryland School of Medicine (UM SOM), has received the 2016 Vanderbilt University School of Medicine Distinguished Alumni Award.

Neuzil, who is also the deputy director of the UM SOM Institute for Global Health, will be honored during VUSM’s 2016 Reunion festivities, Oct. 20-22. The award is the highest honor given to Vanderbilt alumni. Thirty-eight recipients have been recognized since the award was first granted in 1983.

“Dr. Neuzil’s career provides a role model to those who are interested in pursuing a career in medicine or public health,” said Ann Price, MD, associate dean of Alumni Affairs at VUSM. “I hope by highlighting her achievements others will be inspired to walk their own distinguished career paths that will one day allow them to help others as she has.”

Dr. Neuzil, who is also a professor of medicine and pediatrics at UM SOM, has a national and international reputation for her work in infectious disease and epidemiology. After graduating summa cum laude from the University of Maryland in 1983 and receiving her medical degree from Johns Hopkins University in 1987, Neuzil completed her residency and fellowship training at Vanderbilt and was appointed the Hugh Morgan Chief Resident in Medicine. She received her MPH degree from VUSM in 1998.

"This is a prestigious award, and one that Dr. Neuzil thoroughly deserves,” said Christopher Plowe, MD, MPH, founding director of the UM SOM Institute for Global Health, as well as Professor of Medicine, of Microbiology and Immunology, and of Epidemiology and Public Health at the school. “It underscores the importance of the work on vaccines and global health that she is doing here at UM SOM."

Dr. Neuzil has held academic appointments at both Vanderbilt and the University of Washington as an infectious disease physician and epidemiologist. She also spent a decade working with PATH, a global health non-profit organization, where she led their vaccine access and delivery team.  

She has led or been involved in pivotal vaccine trials that have influenced vaccine policy worldwide. A strong advocate for translating research results into vaccine policies, she was a key driver in the many changes in the influenza policy over the last two decades in the United States, and on an international level, her research helped shape rotavirus vaccine policy. Her research has focused on a variety of vaccines, including influenza, rotavirus and RSV, as well as other areas like maternal immunization, optimizing vaccine use and overcoming barriers to sustainable vaccine uptake in low resource settings.   She is continuing this work at UM SOM.

She has more than 160 scientific publications on vaccines and infectious diseases. Her extensive experience in domestic and international policy includes memberships on the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices and the Pandemic Influenza Task Force for the Infectious Disease Society of America. She has worked with the World Health Organization, served as a member of the Strategic Advisory Group of Experts’ rotavirus working group and served as a member of the Global Advisory Committee on Vaccine Safety working group on the safety of vaccines in pregnancy. 

She currently chairs the steering committee for the CDC-sponsored Ebola vaccine trial in Sierra Leone.

“Dr. Neuzil has spent her career working to improve vaccines for those who are most in need,” said E. Albert Reece, Vice President, Medical Affairs at the University of Maryland and the John Z. and Akiko K. Bowers Distinguished Professor and Dean at UM SOM. “This award highlights her impressive accomplishments, and really bodes well for the future of the Institute for Global Health and the Center for Vaccine Development.”

About the University of Maryland School of Medicine

The University of Maryland School of Medicine was chartered in 1807 and is the first public medical school in the United States and continues today as an innovative leader in accelerating innovation and discovery in medicine. The School of Medicine is the founding school of the University of Maryland and is an integral part of the 11-campus University System of Maryland. Located on the University of Maryland’s Baltimore campus, the School of Medicine works closely with the University of Maryland Medical Center and Medical System to provide a research-intensive, academic and clinically based education. With 43 academic departments, centers and institutes and a faculty of more than 3,000 physicians and research scientists plus more than $400 million in extramural funding, the School is regarded as one of the leading biomedical research institutions in the U.S. with top-tier faculty and programs in cancer, brain science, surgery and transplantation, trauma and emergency medicine, vaccine development and human genomics, among other centers of excellence. The School is not only concerned with the health of the citizens of Maryland and the nation, but also has a global presence, with research and treatment facilities in more than 35 countries around the world. http://medschool.umaryland.edu/

Contact

Office of Public Affairs
655 West Baltimore Street
Bressler Research Building 14-002
Baltimore, Maryland 21201-1559

Contact Media Relations
(410) 706-5260

Related stories

    Thursday, July 02, 2020

    UMSOM Researchers Help Weigh Role of Human Challenge Studies for COVID-19 Vaccine Development

    Members of the National Institutes of Health’s (NIH) Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Working Group, which includes Kathleen Neuzil, MD, MPH, DTPH, the Myron M. Levine, MD, DTPH Professor in Vaccinology and Director of the Center for Vaccine Development and Global Health (CVD) at the University of Maryland School of Medicine (UMSOM), assessed the practical considerations and prerequisites for using controlled human infection models (CHIMs) to support development of a SARS-CoV-2 Vaccine.


    Friday, September 20, 2019

    UM School of Medicine's Center for Vaccine Development and Global Health Receives NIH Contract of up to More than $200 Million for Influenza Research

    Kathleen Neuzil, MD, MPH, Professor of Medicine and Pediatrics and Director of the Center for Vaccine Development and Global Health (CVD) at the University of Maryland School of Medicine (UMSOM) and Dean E. Albert Reece, MD, PhD, MBA, announced that CVD has been awarded a contract from the National Institute of Allergy and Infectious Diseases (NIAID), with total funding up to more than $200 million over seven years if all contract options are exercised.


    Friday, March 08, 2019

    UMSOM Researchers Unveil Progress and Challenges in Introducing Typhoid Conjugate Vaccine in Sub-Saharan Africa and Asia

    Each year there are nearly 11 million cases of typhoid, a disease that is spread through contaminated food, drink and water. Researchers at the University of Maryland School of Medicine are leading an international consortium that is studying the impact of a typhoid conjugate vaccine (TCV) in an effort to accelerate introduction of the vaccine in countries in sub-Saharan Africa and Asia where there is a high burden of typhoid.


    Monday, December 03, 2018

    UMSOM and Groupe De Recherche Action En Sante Begin Second Typhoid Conjugate Vaccine Study in Africa

    A new study has been launched in Burkina Faso for Bharat Biotech’s typhoid conjugate vaccine (TCV). It is the second clinical study underway in Africa for the vaccine and the first in West Africa. The vaccine study is a joint effort by the Center for Vaccine Development and Global Health (CVD) at the University of Maryland School of Medicine, (UMSOM) and Groupe de Recherche Action en Santé (GRAS) in Burkina Faso.


    Friday, November 02, 2018

    UMSOM Global Health Expert Named to Prestigious World Health Organization Immunization Panel

    Kathleen Neuzil, MD, MPH, Professor of Medicine and Pediatrics and Director of the Center for Vaccine Development and Global Health (CVD) at the University of Maryland School of Medicine (UMSOM), has been named to the World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE) on Immunization.


    Monday, April 23, 2018

    UM School of Medicine Launches Newly Organized Center for Vaccine Development and Global Health Under Leadership of International Vaccine Expert Dr. Kathleen Neuzil

    University of Maryland School of Medicine (UMSOM) Dean E. Albert Reece, MD, PhD, MBA, announced today the launch of a newly organized Center for Vaccine Development and Global Health (CVD). The new Center will be led by UMSOM Professor of Medicine and Pediatrics, Kathleen Neuzil, MD MPH, FIDSA, one of the world’s most influential research scientists and advocates in vaccine development and policy.


    Thursday, September 28, 2017

    UM SOM Vaccine Expert Warns of Risks of Influenza to Older Populations

    “Protect yourself and others by getting the flu shot” was the message from Kathleen Neuzil, MD, MPH, FIDSA, Director of the Center for Vaccine Development (CVD) at the University of Maryland School of Medicine (UM SOM). Dr. Neuzil was among the speakers at a press conference hosted by the National Foundation for Infectious Diseases. U.S. Secretary of Health and Human Services, Thomas E Price, MD, also spoke at the press conference and urged people to get their flu shot. The panel members all received their flu shots following the press conference.


    Monday, May 15, 2017

    U.S. CDC Recommends Use of Cholera Vaccine Developed by University of Maryland School of Medicine

    A cholera vaccine developed by scientists at the University of Maryland School of Medicine’s Center for Vaccine Development (CVD) has been recommended by the U.S. Centers for Disease Control and Prevention (CDC) for use as a protection for U.S. adults traveling to areas with cholera. The CDC’s latest recommendation was published on May 11, in Morbidity and Mortality Weekly Report.


    Thursday, May 04, 2017

    UM School of Medicine Researchers Receive $9 Million Grant for Malaria Research

    The University of Maryland School of Medicine has been awarded an International Center of Excellence for Malaria Research (ICEMR) grant by the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID), one of seven ICEMRs awarded worldwide. With funding of more than $9 million over seven years, the grant will be used to research and develop new tools to help eliminate drug-resistant malaria in Myanmar and neighboring countries in Southeast Asia.


    Thursday, November 10, 2016

    International Consortium Receives $36.9 Million Grant to Fight Typhoid

    Typhoid fever, a bacterial infection that causes high fever and other disabling symptoms, remains a serious global problem in the developing world: it kills almost a quarter of a million people annually, and infects about 21 million.


    Thursday, September 22, 2016

    University of Maryland School of Medicine Holds Inaugural Global Health Summit

    The Institute for Global Health (IGH) at the University of Maryland School of Medicine (UM SOM) will hold its first Global Health Summit on September 26. The event, which will take place from noon to 6 p.m. in the SMC Campus Center at 621 W. Lombard Street, will seek to foster collaboration among scientists and promote new and innovative global health research at UM SOM, as well as at other schools at the University of Maryland, Baltimore (UMB). Faculty and staff from UM SOM, as well as other schools are welcome at the event.


    Thursday, August 04, 2016

    UM SOM is Center Stage in Testing National Institutes of Health Zika Vaccine

    UM SOM'S Center for Vaccine Development, tapped previously for Ebola vaccine, now steps up to help develop first Zika vaccine.


    Wednesday, July 06, 2016

    UMSOM Begins Malaria Vaccine Trial in Burkina Faso

    Malaria is one of the world’s deadliest diseases: it infects hundreds of millions of people every year, and kills about half a million, most of them under five years of age.


    Wednesday, June 29, 2016

    UM SOM Researchers Awarded Grant to Use Innovative Alternative to Autopsies to Better Understand Child Mortality

    Kathleen Neuzil, MD, MPH, director of the Center for Vaccine Development (CVD) at the University of Maryland School of Medicine (UM SOM), and UM SOM Dean E. Albert Reece, MD, PhD, MBA, announced today that CVD has been awarded a large grant from the Bill & Melinda Gates Foundation for research that will help determine why so many children under five are dying in the world’s poorest countries. The grant will fund use of an innovative alternative to traditional autopsy known as minimally invasive tissue sampling. The technique, which involves the collection of tissue samples with fine needles, allows researchers to quickly identify the cause of death, and help illuminate ways to save lives and improve the health of children in these vulnerable areas.


    Friday, June 24, 2016

    Investiture Celebrates the Courage and Passion of Two University Warriors

    In a packed Westminster Hall, with one of the largest audiences to date for any investiture ceremony, Christopher Plowe, MD, MPH, was named the Frank M. Calia, MD Professor of Medicine.